Answer
Phesgo is contraindicated in patients with known hypersensitivity to pertuzumab, trastuzumab or any of its excipients.
Sources for this answer
- Phesgo 600 mg/600 mg, 1200 mg/600 mg solution for injectionRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 7Document updated
Sources checked